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The development of biomaterials with controllable interfacial features which have the capability to
instruct cellular behavior are required to produce functional scaffolds for the treatment of spinal
cord injury (SCI). Here, poly-e-caprolactone surfaces were biofunctionalized via layer-by-layer (LbL)
deposition. The polyelectrolytes employed in this LbL technique were heparin and poly-L-lysine
(PLL), the latter being chosen to improve cell adhesion and the subsequent cellular function of
in vitrocultured neural progenitor cells. Material characterization results confirmed the deposition
of well structured multilayers. Cell culture studies revealed significant differences in the cellular
response to these adhesive/nonadhesive (PLL/heparin) polyelectrolyte multilayer (PEM)surfaces,
with neurite outgrowth being significantly promoted on the PLL terminating layers. In addition,
brain derived neurotrophic factor (BDNF) was adsorbed onto the LbL surfaces. This combined
chemical and biological effect was then characterized in terms of neurite length along with the full
length/truncated isoform 1 tyrosine kinase receptor (TrkB-FL/TrkB-T1) and growth associated
protein-43 mRNA levels. Here, the authors report the differential effect of adsorbed and soluble
BDNF of different concentrations. Adsorbed BDNF promoted neurite outgrowth and led to elevated,
sustained TrkB mRNA levels. These findings highlight the potential of PEM biofunctionalized
surfaces with integrated chemical and neurotrophin supportive cues to overcome SCI inhibitory
environments and to promote regeneration.VC 2011 American Vacuum Society.
[DOI: 10.1116/1.3656249]
I. INTRODUCTION
Due to the inhibitory physiological micro-environment
associated with spinal cord injury (SCI)1,2 and the restricted
regenerative capacity of axons in the central nervous system,3
spontaneous regeneration is limited. Current research has
shown improved functional recovery using stem/progenitor
cell based therapies4,5 and tissue engineering scaffolds are
now being exploited to accommodate the transplanted stem/
progenitor cells, which are capable of both self-renewal and
differentiation into all relevant neural phenotypes at the
lesion site to replace injured or lost cells.6–9 Scaffolds must
be engineered to not only provide a supportive and favorable
cellular micro-environment for transplanted stem cells, but to
also include guidance cues for cell migration and neurite out-
growth from endogenous and exogenous cell sources.10,11
However, many biodegradable scaffolds have a limited inter-
action with cells, due to their high hydrophobicity and lack of
bioactive groups,12 presenting the current challenge of bio-
functionalizing scaffold surfaces to improve cellular interac-
tions and to actively control biological responses, such as cell
adhesion,13 proliferation,14 and differentiation.15
Layer-by-layer (LbL) deposition, where the process takes
place in aqueous environments, has the advantage of being
capable of uniformly biofunctionalizing complex 3D scaf-
folds with interconnected porosity.14,16 The technique
involves the sequential deposition of oppositely charged pol-
yelectrolytes to build up polyelectrolyte multilayers (PEMs)
with control over film thickness, biofunctionality, and sur-
face stiffness by changing polyelectrolyte pairs, pH, ionic
strength, and the concentration of the crosslinking
agent.17–19 Entropy is the primary driving force for LbL dep-
osition,20 which relies on charge density matching and over-
compensation of oppositely charged polyelectrolytes.21
Consequently, there is less restriction to the underlying sub-
strate chemistry such as defects and trace contaminations,22a)Electronic mail: john.forsythe@monash.edu.
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and moreover, numerous charged biomolecules including
polysaccharides,13,23 polypeptides, and proteins24,25 can be
used to produce surfaces tailored specifically for a variety of
applications. Here, positively charged poly-L-lysine (PLL)
which, at physiological conditions, is well known as a pro-
moter of cell adhesion,26,27 and negatively charged heparin
that has anti-inflammatory28,29 and anti-adhesive30 proper-
ties along with its specific binding of growth factors,31,32
were used. These deposited PEMs also provide abundant
adsorption sites or reactive moieties for growth factor incor-
poration,23 such as brain-derived neurotrophic factor
(BDNF) which we exploited in this study.
The BDNF binds with high affinity to the TrkB receptor,
which is wildly expressed in the central nervous system and
plays a crucial role in cell survival and neurite outgrowth for
a variety of neuronal phenotypes.33,34 Truncated forms,
which lack the tyrosine kinase component, along with the
full length isoform of the TrkB receptor, can play an impor-
tant role in neurogenesis in vivo. Following an SCI, regener-
ation is hindered due to the inhibitory environment and low
levels of endogenous BDNF.35 Therefore, the delivery of ex-
ogenous BDNF to the injury site is of great importance. Tra-
ditional methods used to deliver BDNF (e.g., vein
injection36 and osmotic micropumps37) are limited due to
the extremely short plasma half-life of BDNF (0.92min)36
and the restricted long range interstitial diffusion in the cen-
tral nervous system.38,39
Recent research has focused on various polyelectrolyte
pairs interfaced with biological systems; however, most of
the work involves the deposition of PEMs on silicon, gold,
or glass substrates, and the use of tumor cells and/or fibro-
blasts as a model to study the cellular adhesion, proliferation,
and cytotoxicity response.40 The aim of this study was to
construct multilayers directly onto a poly-e-caprolactone
(PCL) film, a biomaterial that has been utilized both
in vitro10 and in vivo41 for neural tissue engineering in the
past. We investigated if optimizing the interfacial features
using biofunctionalization could facilitate controlled cellular
responses of neural progenitor cells (NPCs), which provides
insight to the application of LbL biofunctionalzed scaffolds
in vivo. To overcome the drawbacks of soluble neutrophins
and to combine the chemical support (adhesive/spreading)
with neurotrophic support, BDNF was physically adsorbed
onto the PEMs, and NPC cultures were performed to study
the combined cues and to compare adsorbed and soluble
BDNF.
II. MATERIALS AND METHODS
A. LbL deposition on PCL substrates
A PCL (inherent viscosity¼ 1.00–1.30, Absorbable Poly-
mers, USA) was compression molded with a 25 kN pres-
sure at 80 C for 30 s to form a 2D film (average
thickness¼ 0.34mm). These were then cut into 10 10 mm2
substrates and washed in 50 v/vol. % ethanol/deionized
water for 1min in an ultrasonic bath. The surfaces of the
substrates were activated by submersion in 20mg/mL PEI
(polyethyleneimine, molecular weight¼ 750 000, Sigma-
Aldrich, St Louis, MO, USA) in phosphate-buffered saline
(PBS) buffer (pH¼ 7.4, Sigma-Aldrich, St Louis, MO,
USA) for 2 h. A StratoSequence VI robot (nanoStrata Inc.,
USA) was used to carry out the automatic dip-rinse process.
The LbL depositions on PEI activated substrates were con-
ducted at pH¼ 7.4 in the PBS buffer. The substrates were
then dipped into 5mg/mL heparin (180 USP units/mg
Sigma-Aldrich, St Louis, MO, USA) in the PBS buffer for
15min, followed by rinsing in the PBS buffer for 5min.
They were treated the same way using 1mg/mL PLL (mo-
lecular weight¼ 130 000 Sigma-Aldrich, St Louis, MO,
USA) in the PBS (pH¼ 7.4) buffer. When the desired num-
ber of PEMs were deposited, the samples were collected for
crosslinking or characterization. The PEMs are named by
the type and number of the outermost polyelectrolytes
(the terminating layer of the PEMs). For example, the first
heparin deposition on PEI treated PCL (PCL/PEI/heparin)
is denoted as H1, and the third PLL deposition (PCL/PEI/
heparin/PLL/heparin/PLL/heparin/PLL) is denoted as P3.
The samples for the water contact angle and in vitro cell
culture were crosslinked by immersion in 2 w/vol. % N-(3-
dimethylaminopropyl)-N0-ethylcarbodiimide hydrochloride
in the PBS for 2 h, followed by thorough washing in deion-
ized water.
B. Quartz crystal microbalance with dissipation
(QCM-D) monitoring of LbL deposition
Gold coated quartz crystals were cleaned via UV-ozone
treatment for 10min, followed by washing in piranha solu-
tion of 5:1:1 (deionized water:ammonia:H2O2) and rinsed
thoroughly in deionized water. The crystals were subse-
quently soaked in 5mM methyl 3-marcaptopropionate
(Sigma-Aldrich, St Louis, MO, USA) in absolute ethanol
(MERCK Pty. VIC, Australia) overnight to provide a supe-
rior surface for the subsequent coating of the PCL. The
alkane-gold crystal was attached to a spin-coater (Laurell
Technologies Corp.); a drop of 0.05 g/mL PCL solution in
tetrachloroethane (Sigma-Aldrich, St Louis, MO, USA) was
placed on the center of the crystal, and then spun for 1min at
6000 rpm to obtain a PCL thin film on the crystal. The PCL
coated crystal was placed in a clean fume hood to allow re-
sidual solvent to evaporate, and then characterized by atomic
force microscopy (AFM) and scanning electron microscopy
(SEM, see the following text for details) to ensure full cover-
age without pin holes or large cracks prior to quartz crystal
microbalance with dissipation (QCM-D) (Q-Sense E4, Swe-
den) analysis of the deposition process. This was performed
by initially pumping the PBS buffer through the analysis
chamber until the signal was stabilized. Each time the buffer
or polyelectrolyte solution was pumped into the analysis
chamber a single injection of 500 lL over 54 s was
employed. The measurements were taken continuously at the
fundamental frequency (5MHz), 3rd, 5th, and 7th overtones.
The fundamental frequency was ignored since it was signifi-
cantly affected by the crystal mounting. Data analysis and
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modeling were performed using QTools software provided
by Q-Sense. For soft films, the film thickness was calculated
by the viscoelastic model, since the Sauerbery model does
not reflect the true values of viscoelastic coatings.42
C. Water contact angle (CA) measurements
Crosslinked PEMs were used for water contact angle
(CA) measurements. Hydrophilicity of the PEMs was deter-
mined by CA analysis, using the standard sessile drop tech-
nique43 on a video-based CA meter (Technical data OCA
20) at room temperature. A single water droplet was placed
on the polymer surface by raising the vertically translating
stage containing the substrate toward a water-filled glass sy-
ringe and capturing the droplet when a stable contact angle
was obtained. The CAs were measured on CCD camera
images using SCA202 software (Dataphysics, Germany).
Measurements were performed at 6 random locations on
PCL, PEI activated PCL, and H1 to H8 PEM surfaces, which
had been pre-dried overnight in a vacuum oven.
D. Atomic force microscopy (AFM) analysis
The PCL coated QCM crystal surfaces and H8 surfaces
built up on PCL coated QCM crystals were examined by
AFM (Nanosurf Mobile S, Switzerland) in noncontact mode
with a spring constant of 48N/m. Three random areas of
50 50 lm2 size were scanned for each sample.
E. BDNF adsorption
Crosslinked P6 and H7 terminating PEM samples were
chosen for BDNF adsorption and subsequent cell culture
studies, since the coatings were found to be uniform after
this number of layers. The samples were sterilized with 70%
ethanol, and air dried in a laminar flow hood for 30min
before being soaked in PBS solutions containing 0.0001,
0.001, 0.01, 0.1, 1, and 10 lg/mL BDNF (Recombinant
human BDNF, R&D systems, Minneapolis, USA) at 4 C
overnight. The BDNF adsorbed samples were prepared in
triplicate for ELISA and in vitro cell culture.
F. Enzyme-linked immunosorbent assay (ELISA)
The BDNF adsorbed PEMs were washed three times in
0.05 v/vol. % Tween-20 (Sigma-Aldrich, St Louis, MO,
USA) in PBS (PBS-T) for 10min, and were then blocked
with 5 v/vol. % normal goat serum in the PBS-T (blocking
buffer) for 40min. They were subsequently incubated with
rabbit anti-BDNF diluted (1:750, Abcam, Cambridge, MA,
USA) in blocking buffer at 37 C for 2 h, before being
washed in PBS-T for 10min (4 times) and incubated with
anti-rabbit IgG and HRP-linked antibody (Cell Signaling
Technology, Danvers, MA, USA) and diluted in PBS-T
(1:3000) at 37 C for 1 h. They were again washed in the
PBS-T for 10min (four times) and transferred to a new 96-
well culture plate where they were mixed with stabilized per-
oxide and chromogen solution (3,30,5,50 – tetramethylbenzi-
dine, R&D systems, Minneapolis, MN, USA) for color
development and incubated for 15min at room temperature.
The reaction was stopped by adding 1M HCl into each well
and the supernatant was analyzed using a plate reader
(Benchmark Plus, Bio-RAD, NSW, Australia) at an absorb-
ance wavelength of 452 nm. Additional BDNF free and
adsorbed PEMs were prepared for ELISA, with the latter
using PBS instead of rabbit anti-BDNF antibody to serve as
negative controls for background subtraction.
To test for desorption of BDNF into solution, BDNF
adsorbed PEMs (the three highest concentrations used for
in vitro culture (0.1, 1, and 10 lg/mL) were incubated in trip-
licate in 50 lL of sterile PBS at 37 C for 6 days. The super-
natant was collected every 24 h and replaced with fresh
sterile PBS. Any desorbed BDNF was allowed to adhere to a
Maxisorp plate (Nunc-Immuno, Thermo Fisher Scientific,
VIC, Australia) at 4 C overnight, then quantified by ELISA
as previously described.
G. Cell culture
All cell culture reagents used were purchased from Invi-
trogen, Mulgrave, Australia, unless specified. Mouse embry-
onic stem cells (ES, W9.5) were cultured in Dulbecco’s
modified Eagle’s medium (high glucose), supplemented with
15 v/vol. % fetal bovine serum (FBS), 1 v/vol. % nonessen-
tial amino acid solution, 50 unit/mL penicillin, 50 lg/mL
streptomycin, 50mM 2b-mercapoethanol and 103 unit/mL
leukemia inhibitory factor (Millipore, NSW, Australia). The
ES cells were seeded at a density of 5 104 cells/cm2 on mi-
tomycin treated mouse embryonic fibroblasts (MEF, derived
from 129 mouse) prepared earlier on gelatin-coated culture
plates using the same seeding density, with sub-culturing
every third day. ES/MEF co-cultures were collected, re-
suspended, and then incubated in Iscove’s modified Dulbec-
co’s medium (IMDM) with 10 v/vol. % FBS for 40min to
deplete the MEFs, since MEFs adhered to the culture plate
earlier than the ES. Purified ES cells were then re-suspended
at a density of 5 103 cells/mL in a chemically defined me-
dium composed of 49 v/vol. % IMDM, 49 v/vol. % F12 nu-
trient mix, 1 v/vol. % chemically defined lipid concentrate, 1
v/vol. % insulin-transferrin-selenium-X, 0.5 w/vol. % bovine
serum albumin (BSA, Sigma-Aldrich, St Louis, MO, USA),
0.04 lL/mL a-monothioglycerol (MTG, Sigma-Aldrich, St
Louis, MO, USA), 2mM L-glutamin, 25 unit/mL penicillin,
25 lg/mL streptomycin, and 10 ng/mL bFGF, in nonadherent
96-well plates (Corning Inc., MA, USA) and allowed to
expand to form larger embryoid bodies (EBs) over a 7 day
period. After EB formation, neural inductive stimulation
using bFGF led to a high fraction of NPCs. The aggregated
EBs were then mechanically dissociated and the NPCs were
seeded (1 105 cells/cm2) onto the PEM substrates and cul-
tured in Supplement-free Neuronbasal A medium supple-
mented with 2mM L-glutamine, 50 unit/mL penicillin,
50 lg/mL streptomycin, 1 v/vol. % insulin-transferrin-sele-
nium-general, 1 v/vol. % N-2 supplement and 1 v/vol. % B-
27 serum-free supplement for 5 days without medium
change.
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Culture groups included positive controls (PLL coated
coverslips); negative controls (unmodified PCL); test groups
that included all PEMs from P4 to H8 without BDNF, as
well as P6, H7 PEMs with adsorbed/soluble BDNF; and cor-
responding biological controls (adsorbed BDNF with its bio-
activity inhibited by sheep anti-BDNF antibody, Millipore,
NSW, Australia). The PLL positive controls were prepared
by incubating coverslips in 10 lg/mL PLL for 1 h before
rinsing with MilliQ water prior to seeding. The PEM sub-
strates without BDNF were sterilized by 70% ethanol, fol-
lowed by air-drying for 30min in a laminar flow hood. The
preadsorbed BDNF (P6 and H7 layers) were washed in sterile
PBS for 10min (three times) prior to culture. The BDNF bio-
activity inhibition was achieved by subjecting the cell suspen-
sion to sheep anti-BDNF antibody (5 lg/mL) which was then
seeded onto the PEM substrates.44 As a control, soluble
BDNF was also added into the media of the P6 and H7 layers
prior to seeding at concentrations of 10 and 50 ng/mL, respec-
tively. All in vitro culture groups are summarized in Table I.
H. Immunocytochemistry
The PEMs and control groups were immunolabeled for
neuronal markers after 5 days culture. Samples were fixed in
4 w/vol. % paraformaldehyde for 10min, washed in PBS,
permeabilized in 0.2 v/vol. % Triton-X100 (Sigma-Aldrich,
St Louis, MO, USA) for 5min before additional washing in
PBS. The samples were then quenched in freshly prepared
0.1 w/vol. % sodium borohydride (Sigma-Aldrich, St Louis,
MO, USA) in PBS for 5min before subsequent washes. Non-
specific antibody binding was prevented by blocking all
samples with 3 v/vol. % normal goat serum (Vector Labora-
tories Ltd. UK) for 3 h, followed by PBS washing. Samples
were then incubated at 4 C overnight in the following pri-
mary antibody solutions (dilution was 1 w/vol. % BSA/
PBS), mouse-anti-bIII-Tubulin (1:800) for neuronal lineages
and rabbit-anti-GFAP (1:1000, DAKO) for astrocytes. In
addition, rabbit-IgG (1:1000) was used to stain PLL coated
glass coverslips as a negative control, instead of the primary
antibody (rabbit-anti-GFAP), to eliminate false positive
staining unique to this particular antibody. Secondary anti-
bodies, anti-mouse Alexa Flour 568 (1:1000) for neurons
and anti-rabbit Alexa Flour 488 (1:1000) for astrocytes, were
then incubated simultaneously on all samples for 1 h, before
washing 3 times in PBS and being counterstained with
40, 6-diamidino-2-phenylindole (DAPI) nuclear stain (1:10,000)
for 20min.
I. RNA preparation and real-time polymerase chain
reaction (RT-PCR)
Cells after 5 days of culture on the PEM surfaces with/
without BDNF were collected through subjection to 0.25
w/vol. % trypsin, followed by centrifugation at 80 g before
being re-suspended in 200 lL of PBS. Following this, total
RNA was extracted from the cells using a high pure RNA
isolation kit following the manufacturer’s protocol (Roche,
NSW, Australia). A total of 1.5 lg of RNA from each culture
group was reverse transcribed to cDNA in a thermal cycler
(MyCycler, Bio-RAD, NSW, Australia) using the Super-
Script III First-Strand Synthesis System. Primer pairs (Gene-
Works, SA, Australia) used in the real-time polymerase
chain reaction (RT-PCR) study are listed in Table II.
Sybr green mixtures (Invitrogen, Mulgrave, Australia)
were used for real-time PCR reactions. The amplification
program started with preheating at 95 C for 2min, prior to
40 cycles of 95 C for 15 sec, 54.6 C for 15 sec, and 68 C
for 20 sec, which was preceded by running a melting curve
analysis. The RT-PCR products were mixed with a loading
buffer (5:1), and separated by agarose gel electrophoresis (2
w/vol. % agarose gel with 0.005% ethidium bromide) to fur-
ther confirm the single and specific amplification product
that was measured by RT-PCR for each primer pair. The
mRNA fold increase was calculated using the 2DDCt
method. The PCR efficiencies were determined by a series
of tenfold dilution templates, where standard curves showed
TABLE I. Control and PEM test groups for in vitro culture.
Without BDNF With BDNF
Control Test Test Form of BDNF BDNF concentration/density
PLL coated coverslip;
Unmodified PCL
P4 P5 P6 Soluble 10
P6 P7 (ng/mL) 50
H5 H6 H7 Adsorbeda (nm/cm2) 1.29
H7 H8 2.81
aValues determined by ELISA.
TABLE II. Designed primers for RT-PCR study.
Gene Primer sequence (50- 30)
TrkB-T1 forward: TGGTGATGTTGCTCCTGCTCAAGT
reverse: CCCATCCAGTGGGATCTTATGAAAC
TrkB-FL forward: ACTTTGGCATCACCAACAGTCAGC
reverse: AGGTTGTAGCACTCGGCAAGGAAA
GAP-43 forward: TGGTGTCAAGCCGGAAGATAA
reverse: GCTGGTGCATCACCCTTCT
Housekeeping gene: forward: TGTTCCTACCCCCAATGTGT
Glyceraldehyde-
3-phosphate
reverse: CCCTGTTGCTGTAGCCGTAT
Dehydrogenase (GAPDH)
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efficiencies of between 100–110%, which meet the assump-
tion for the 2DDCt method.
J. Fluorescence imaging and quantitative analysis of
cultured NPCs
The PCL substrates where PEMs had been deposited and
coverslips with adsorbed PLL were imaged using a fluores-
cence microscope (Provis, Olympus, Japan) and Analysis-
Professional software (Olympus Soft Imaging, Japan) for
capturing images. The entire culture area of the scaffolds
and coverslips was also mapped sequentially using a scan-
ning epifluoresence microscope (XL20 Dotslide, Olympus,
Japan) for subsequent quantitative analysis. Fluorescence
levels and pixel counting were performed using Image-J
software (National Institutes of Health, USA). To obtain ran-
dom sampling, the entire culture surface image was divided
into a 64-grid; then a random coordinate was generated by
computer to choose the grid to be analyzed (1.3 0.8 mm2)
each time. Quantification of neurite density per area was
estimated by counting the number of pixels occupied by
bIII-tubulin positive staining based on a previous protocol,45
with DAPI positive staining to exclude the cell cluster
regions. The DAPI positive pixels were also used to mini-
mize the cell body area (bIII-tubulin positive) in the noncell
cluster regions for the calculation of the neurite density;
however, the random sampling and sufficient sample num-
bers (n¼ 15) avoided a bias in the quantification due to ran-
dom cell distribution (cell density) on the scaffolds.
Threshold levels of intensity were constant and used to
determine the optimal resting image in a sample of five ran-
dom fields. The density of neurites was then expressed as
percentage coverage by the relationship,
Neurite density ¼ pixels bIII Tubulin positive stainð Þ  pixels DAPI positive stainð Þ
Total pixels of the chosen field
: (1)
The neurite length was measured on these randomly selected
fluorescence images with an ImageJ plugin – NeuronJ.46 The
tracing and quantification was performed on all visually dis-
tinguishable neurites of selected analysis areas (n¼ 50). The
mean values of neurite coverage per unit area (percent) of
scaffolds and the mean values of neurite length were
determined.
K. Statistics
The neurite density comparisons on different PEM surfa-
ces without BDNF were made between test groups, and the
neurite length on the PEMs with/without adsorbed/soluble
BDNF was compared between all culture groups using the
Kruskal-Wallis test with Dunn’s multiple comparisons test.
For RT-PCR statistics analysis, all BDNF (adsorbed/soluble)
treated groups were compared to the untreated group (no
BDNF) with an unpaired t-test with Welch correction. The
mRNA fold increase was also compared between adsorbed
BDNF groups and soluble groups using a one-way analysis
of variance (ANOVA) with Tukey post-test. All statistical
analyses were performed using GraphPad Instat software
(GraphPad Software, Inc.); p-values of less than 0.05 were
considered to be significantly different.
III. RESULTS
During the entire LbL deposition process a decrease in
the frequency change (Df/, where  is the overtone number)
was observed using QCM analysis. This qualitatively indi-
cated mass deposition and was observed upon each heparin
injection, followed by a slight increase of Df/ during PBS
washes, which plateaus after 5min (Fig. 1). By contrast, the
initial PLL deposition (P1 and P2) only caused a slight drop
of Df/, which then increased after the P3 deposition. How-
ever, during PBS washes for the PLL electrolyte, the Df/
changes were negligible throughout the LbL deposition.
The polyelectrolyte mass deposition is more clearly
shown in the inset of Fig. 1. Both heparin and PLL deposi-
tion contributed to the mass increase during the LbL process.
An exponential growth of heparin/PLL deposition was
observed for all three overtones (the 3rd, 5th, and 7th), and
Df/ showed a frequency dependence on thicker PEMs.
FIG. 1. QCM-D frequency shift (Df/) during LbL deposition; data points
were collected after PBS signal stabilization, with the plot starting from the
PBS wash after PEI activation prior to the PEM deposition. Black arrows
indicate the injection of heparin; gray arrows indicate the injection of PLL.
PBS washes after each deposition step are not indicated in the plot. Note: To
aid clarity, only every 600 points were used from the entire data set to pro-
duce this plot. The inset shows the frequency difference (Df/) after PBS
washes of each polyelectrolyte deposition.
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The total PEM thickness was estimated to be 125 nm
using the viscoelastic model, which assumes that each layer
covers the entirety of the sensor and has a uniform thickness
with homogenous structure.47
The SEM analysis of the PCL coated alkyl-Au showed a
smooth surface (image not shown due to lack of topological
contrast). After the deposition of the H8 layer, the PEM sur-
face was discovered by AFM to be smooth, with only
nanometer-sized surface roughness observed. Line profiles
across the AFM images were also studied and the results
showed no obvious morphology change between layers
[Figs. 2(b) and 2(c)].
The wettability of unmodified PCL, PEI activated PCL,
and PEMs (H1–H8) was characterized by CA measurements.
The CA value dropped from 79 to 71 after PEI activation
(Fig. 3). Subsequent deposition on the PEI activated PCL led
to a regular alternating step change in the CA values, where
heparin surfaces generally showed lower CA values com-
pared to PLL surfaces.
Using our cell culture method, which was adapted from a
previous protocol,49 neural progenitor cells were induced to
differentiate preferentially into neurons. This was confirmed
by our initial culture experiments, which showed the major-
ity of the cells to be neurons (bIII-Tubulin positive), a small
number of astrocytes (GFAP positive), and no oligdendro-
cytes (NG2 positive). Therefore, in subsequent cultures, only
bIII-Tubulin and DAPI staining was performed. Neuronal
FIG. 2. (Color) AFM images of (a) a PCL coated QCM sensor crystal, (b) the H8 PEM surface on the PCL coated QCM sensor crystal, and (c) the line profile
across the H8 AFM image.
FIG. 3. Water contact angle measurements on PCL, PEI activated PCL, and
PEM surfaces from H1 to H8. Error bars show standard deviation; sample
size, n¼ 6.
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spreading was observed on both PLL positive controls and
PLL terminating PEMs, with neurites radially elongating,
and, in some cases, perpendicular side branching at the pe-
riphery of outgrowths was present [Fig. 4(c)]. The PLL ter-
minating PEMs [Figs. 4(b) and 4(c)] had a similar density of
neurites compared to the PLL positive control [Fig. 4(a)]. In
contrast, few cells were found on the unmodified PCL (data
not shown). Similarly, for heparin terminating surfaces,
while some cell colonies were seen to adhere, neurite elon-
gations were relatively short and sparse [Fig. 4(d)]. Based on
the quantified neurite coverage [Fig. 4(e)], cell-substrate
interactions were significantly improved on the PLL termi-
nating surfaces in terms of neurite coverage. Heparin termi-
nating PEM surfaces showed significantly lower (p< 0.001)
neurite coverage than the positive control and surfaces termi-
nating in PLL.
The BDNF was adsorbed on the P6 and H7 terminating
layers, with ELISA showing a linear correlation between the
amount of BDNF in solution (up to 10 lg/mL) and that
adsorbed on the different terminating layers (Fig. 5). To test
the possibility of BDNF desorption, the three highest BDNF
concentrations used for subsequent in vitro cultures (0.1, 1,
and 10 lg/mL) were incubated in sterile PBS for 6 days.
Analysis of the supernatant during this period by ELISA did
not detect the presence of soluble BDNF.
Following BDNF adsorption to P6 and H7 terminating
PEMs, enhanced effects on neuronal differentiation from
NPCs were observed. Figure 6 shows the immunostaining on
P6 surfaces with/without adsorbed or soluble BDNF of dif-
ferent concentrations. However, longer neurites were
observed on adsorbed BDNF surfaces, which was concentra-
tion dependent. The dosage effect (BDNF) was more pro-
nounced when the growth factor was adsorbed on the PEMs,
even at the lowest surface density (0.65 ng/cm2). However,
when adsorbed BDNF was blocked using a BDNF antibody
that was added in the culture media, neurite length dropped
back to a level similar to the groups that were not subjected
to BDNF. [High resolution images chosen from Fig. 6 are
shown in the Appendix (Fig. 9).]
Neurites on the P6 surface without BDNF stimulation had
an average length of 50 lm (Fig. 7). Both adsorbed and solu-
ble BDNF significantly promoted neurite elongation in a
FIG. 4. (Color online) (a) Cells cultured for 5 days on the PLL positive control, (b) P4, (c) P5, and (d) H6 PEM surfaces. The cells were stained by bIII-Tubulin
(red) for neurons and DAPI (blue) for nuclei. Scale bars indicate 100lm in (a)-(d). (e) Day 5 neurite coverage (from cell clusters) on the PLL positive control,
the PEMs from P4 to H8 in the absence of BDNF; error bars show standard deviation of the mean. Sample size, n¼ 15. Unmodified PCL culture groups were
not included in the neurite coverage plot. A significant difference (p< 0.001) was observed between the PLL and heparin terminating layers.
FIG. 5. Amount of BDNF adsorbed on the P6 and H7 surfaces with each
sample being performed in triplicate and quantified by ELISA. Error bars
are shown as standard deviations.
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concentration dependent manner compared with the BDNF
free group. However, significantly longer neurites were
observed for the adsorbed BDNF groups compared to that of
the soluble BDNF. Even at the lowest surface protein density
(0.65 ng/cm2), the mean neurite length was approximately
86 lm compared to 73 lm for 10 ng/mL soluble BDNF
group. Overall, the longest average neurite length (141 lm)
was observed on 2.81 ng/cm2 adsorbed BDNF (on the P6 ter-
minating layer), which is about 3 times greater than the
BDNF negative control and 1.5 times greater than the 50 ng/
mL soluble BDNF group, respectively, for the identical ter-
minating layer. Few cells (individual/clusters) were found on
the H7 with/without adsorbed/soluble BDNF. However, cell
clusters found on the H7 adsorbed/soluble BDNF showed
similar levels of neurite outgrowth to H7 without BDNF.
Quantitative RT-PCR analysis confirmed this synergistic
effect between the adhesive promoting P6 surface and neuro-
trophin support at the level of the induced expression of the
receptor message by the exogenously supplied BDNF. The
TrkB-FL down-regulation was not observed for the 10 ng/
mL soluble group in our study. In contrast, adsorbed
BDNF of different concentrations showed little effect on the
TrkB-T1 mRNA after 1 day. A significant down-regulation
(p< 0.05) of TrkB-T1 was observed for the 50 ng/mL
soluble BDNF after 1 day of culture. The mRNAs of both
TrkB-FL and TrkB-T1 showed fold increases after BDNF
was administered for 5 days, which were dose dependent both
for the adsorbed and soluble forms. Adsorbed BDNF groups
also had a significant effect on the TrkB-T1 mRNA fold
increase compared to the BDNF free control groups and
showed a 10.6-fold increase for the 2.81 ng/cm2 adsorbed
group compared to 3.7-fold for the 50 ng/mL soluble group
(p< 0.05). In contrast to the TrkB mRNA data, the GAP-43
mRNA was observed to have 2.07 - and 3.03-fold increases
(p< 0.01) for the low density/concentration groups, 1.29 ng/
cm2 and 10 ng/ml, respectively, after 1 day of culture. How-
ever, this returned to a similar level to the no BDNF control
groups by day 5.
IV. DISCUSSION
The QCM-D in situ characterization of the PEMs
revealed, to the first approximation, the mass adsorption
upon each PLL and heparin injection. During PBS washing
following each deposition process, Df/ changed differen-
tially for the assembled heparin and PLL surfaces. The PBS
washing after heparin deposition led to a larger increase of
Df/ compared to PLL. The former is due to the removal of
loosely attached heparin during washing. We hypothesize
that the negligible Df/ change during the PBS washing follow-
ing the PLL deposition is due to the loose surface chains from
the heparin electrolyte rearranging into a dense structure once
in contact with the PLL solution and effectively anchoring the
PLL chains on the surface of the PEM,43 which can be attrib-
uted to the higher charge density of heparin compared to PLL.
In addition, the frequency dependence of Df/ (see Fig. 1,
inset) indicated a more pronounced viscoelastic behavior of
PLL/heparin multilayers as the layer thickness increased, which
is also observed in other polyelectrolyte pairs.13,51
The surface chemistry and energetics were characterized
by water contact angles. The CA values are sensitive to
chemical groups within the first 10–20 A˚ of the outermost
surface48 and will therefore reflect the chemical nature of the
PEM surface. The initial decrease of the CA values (from
FIG. 6. (Color online) NPCs cultured on P6 surfaces with adsorbed/soluble
BDNF of different concentrations and corresponding BDNF inhibited groups
(5 days of culture). Cells were marked with bIII-Tubulin (red) for neurons
and DAPI (blue) for nuclei. Scale bar indicates 100lm in all images.
FIG. 7. Neurite length (day 5) of NPCs cultured on P6 surfaces with either
the adsorbed or soluble BDNF of different concentrations and their control
groups (no BDNF and BDNF inhibited groups). The sample size was n¼ 50
and error bars are shown as standard error of the mean. The no BDNF group
showed significant differences to all adsorbed groups and the 50 ng/mL solu-
ble group (p< 0.001, Kruskal-Wallis test); the 2.81 ng/cm2 adsorbed BDNF
group also had a significant difference to its counterpart where biological ac-
tivity was blocked (p< 0.001). Significant differences were observed
between the adsorbed and soluble BDNF groups. Significance represented at
(* p< 0.05, ** p< 0.01, *** p< 0.001).
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79 to 71) after PEI activation indicated the presence of
amine moieties that increased the surface hydrophilicity
(Fig. 3).52 The CA values revealed an alternating step
change with heparin surfaces having lower CA values com-
pared to PLL, which can be attributed to hydroxyl moieties
within the heparin terminating surface and highlights chemi-
cal changes in the terminating layers.49 It was previously
reported that PLL containing polyelectrolyte pairs had com-
plex island formation during initial deposition cycles,24 how-
ever, the mechanism for this has not been reported. Based on
the AFM results in this study, the PEM surface did not show
complex islands and were uniform with nanometer rough-
ness (Fig. 2). Chemical uniformity is critical to clarifying the
interpretation of the cellular response to the interfacial fea-
tures (chemistry, charge, etc.).
The NPCs cultured on the PEMs in the absence of BDNF
were studied to assess the cellular response. The significant
difference between the PLL terminating surfaces to the heparin
surfaces is due to the nonadhesive property of heparin. Figure
4(e) shows significantly different NPCs responses in terms of
neurite coverage (p< 0.05) between the heparin and PLL ter-
minating layers. The surface chemistry within the first 8 nm
(the approximate thickness of each polyelectrolyte layer) suffi-
ciently influenced neurite sensing and adherence, with greater
adhesion and neurite elongation of the PLL terminating layers.
The P6 and H7 terminating layers were subjected to
increasing amounts of BDNF, which adsorbed to their surfa-
ces in a concentration dependent manner (Fig. 5). We pro-
posed that at pH¼ 7.4, the negatively charged heparin surface
would impose an attractive Coulombic force to the positively
charged BDNF, which explains the generally higher protein
adsorption on H7 compared to P6. However, this effect
was not pronounced (p< 0.1) except for the 2lg/mL BDNF
(p< 0.05) concentration, possibly due to significant ionic
screening of the protein and the PEM surfaces.53
Based on the previous culture results and the BDNF
adsorption study, the effect of adsorbed BDNF of different
surface densities on the P6 and H7 layers was studied using
NPCs and compared to soluble BDNF (Fig. 6). Enhanced
neurite outgrowth was observed on P6 surfaces with both
adsorbed and soluble BDNF (Fig. 7). The slightly longer
neurite length of the BDNF inhibited group compared to the
BDNF free group is likely due to incomplete neutralization
of BDNF. Since the anti-BDNF antibody takes time to block
bioactivity, some BDNF proteins may also bind to TrkB
receptors during this time. However, the significant differ-
ence (p< 0.05) between adsorbed BDNF and their corre-
sponding inhibited biological controls (except 0.65 ng/cm2
group) did indicate that BDNF maintained its bioactivity af-
ter adsorption, highlighting that it was sufficient to further
improve neurite outgrowth on the adhesion promoting P6
surfaces. Adsorbed BDNF in combination with the adhesive
surface (P6) enhanced the neurite growth compared to the
adhesive surface alone or with soluble BDNF. This could
provide benefits to the treatment of SCI, since enhanced neu-
rite sprouting and the establishment of new functional con-
nections can repair some lost functions.5,54 However, the
surface adsorbed or soluble BDNF were not able to stimulate
neurite outgrowth from the observed small number of cell
clusters on H7 surfaces, revealing the importance of the ad-
hesive substrate.
Neurotrophic factors stimulate distinct cellular responses
depending on their concentration55 and time course of treat-
ment.56 Acute, prolonged, or gradient changes in the BDNF
concentration trigger diverse cellular responses in neurite
morphology and ligand/receptor binding efficiency.55,57
Since there is no detectable BDNF released from surfaces
into the culture media, the stimulatory effects of the BDNF
was attributed to the adsorbed form. Here we report that the
adsorbed BDNF altered gene expression differently to solu-
ble forms (Fig. 8). The expression of TrkB mRNA is con-
trolled via a protein kinase A (PKA)/cAMP-responsive
element-binding protein (CREB)-dependent mechanism.58
The prolonged up-regulation of TrkB-FL and TrkB-T1
mRNA until day 5 suggested that this process is on the tran-
scriptional level. Therefore, the up-regulation of TrkB
mRNAs for all of the BDNF treated groups reflected the ele-
vated level of intracellular cAMP, which activated TrkB
gene transcription.58 This is in line with previous studies
which have reported that the administration of BDNF to neu-
rons led to a 2–10 fold increase of cAMP.59 Even with a
BDNF surface density of 2.81 ng/cm2, adsorbed BDNF
induced TrkB-FL mRNA expression to a level similar to that
found with the highest soluble concentration of BDNF
(50 ng/mL). The slight and significant down-regulations,
respectively, of TrkB-FL in 1.29 ng/cm2 adsorbed and 50 ng/
mL soluble BDNF groups after 1 day of BDNF treatment
(Fig. 8) is consistent with a previous report that prolonged
high concentrations of soluble BDNF (50 ng/mL) causes
down-regulation of TrkB-FL mRNA after 2 days.50 While it
FIG. 8. TrkB-FL, TrkB-T1, and GAP-43 mRNA expression in cells cultured
on the P6 terminating layers in the presence of different forms of BDNF.
Total RNA was extracted after 1 and 5 days. The sample size was n¼ 4, and
the error bars show the range of values obtained by 2(DDCt6 standard deviation).
Asterisks indicate significant differences compared to no BDNF group:
* p< 0.05, ** p< 0.01, *** p< 0.001 (unpaired t-test with Welch correc-
tion). #, D, and hindicate significant differences (p< 0.05) when comparing
adsorbed BDNF groups to soluble groups (one-way ANOVA with Tukey
post-test).
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is not possible to quantify the level of the TrkB proteins
based on mRNA analysis, it is most likely that elevated
cAMP increased the membrane TrkB receptor protein lev-
els.60 This is likely to increase the chance of further receptor
binding events, along with superior cell-material interfacial
interactions. The high TrkB mRNA transcriptional level of
adsorbed BDNF compared to soluble forms was possibly
due to two reasons: (1) a slower BDNF/TrkB complex inter-
nalization and prolonged activation of down-stream signal-
ing pathways including cAMP/PKA (TrkB gene expression)
and MAPK/ERK (longer neurite length).61,62 Similar influ-
ences have shown that prolonged MAPK/ERK activation of
PC12 cells occurred and led to differentiation stimulated by
immobilized epidermal growth factor;63 (2) the high local
concentration of BDNF that adsorbed on 2D surfaces polar-
ized signaling from the substrate-cell interface, which could
possibly enhance neurite outgrowth.64 However, it should be
acknowledged that covalent immobilization of the BDNF
was not adopted in this study, since covalent immobilized
BDNF will prevent any internalization of the BDNF/TrkB
complex and the subsequent formation of signaling endo-
somes which cause signaling from different locations and
leads to diverse cellular responses.65 We propose that slow
internalization and elevated cAMP levels by adsorbed BDNF
on the PLL surface would provide a promising solution for
transplanted NPCs to overcome the inhibitory environment af-
ter SCI, in addition to the enhanced neurite outgrowth, since
elevated cAMP is reported to overcome myelin-associated
glycoprotein related inhibition.59,66 The assessment of cAMP
levels will be investigated in future research.
The GAP-43 is an abundant membrane protein concen-
trated at the neurite growth cone, and is thought to be associ-
ated with the neurite outgrowth process,67,68 although the
precise mechanism is still unclear. During early neuronal de-
velopment, GAP-43 protein secretion relies on abundant
mRNA levels, which then decline during postnatal develop-
ment.69 Given that BDNF was reported to increase the GAP-
43 mRNA level,37,70 we endeavored to determine if an ele-
vated level of GAP-43 mRNA occurred in response to the
BDNF treatment, potentially leading to over-expression of
GAP-43 and subsequently inducing neurite outgrowth71,72 in
addition to the ERK signaling pathway that promotes neurite
outgrowth. The response of GAP-43 to the BDNF was very
different when compared to TrkB mRNA. A 2-3 fold
increase was observed only for lower density/concentration
groups (1.29 ng/cm2 and 10 ng/mL) of either adsorbed or
soluble BDNF, however fold changes dropped back to a sim-
ilar level to the nontreated group after day 5. A similar short-
lasting mRNA increase was reported in a previous in vivo
study,70 but declined only after 14 days. As revealed by
immunostainning, the longest neurites were found on the
2.81 ng/cm2 adsorbed BDNF group, followed by the 1.29 ng/
cm2 group, which indicated that the amount of GAP-43 is
sufficient for normal neurite outgrowth during early differen-
tiation. However, the elevated mRNA probably did not cor-
relate to a sufficiently high protein level to induce neurite
sprouting.71
V. CONCLUSION
The PCL surfaces were successfully biofunctionalized via
LbL deposition, with smooth and chemical uniform PEMs
deposited. The cellular response of NPCs was significantly
different in terms of neurite coverage and length on heparin
or PLL terminating layers in the absence of BDNF, with the
latter showing remarkable improvement in cell-substrate
interaction compared to unmodified PCL. The BDNF alone,
in either adsorbed or soluble form on heparin terminating
layers, was insufficient to stimulate neurite outgrowth, while
the combined effect of an adhesive interface and presenta-
tion of BDNF revealed pronounced stimulatory effects. The
overall density/concentration dependence on neurite length
was observed for the adsorbed and soluble BDNF stimula-
tion, while the adsorbed BDNF enhanced the outgrowth
compared to the soluble form. This enhancement was attrib-
uted to sustained activation from the BDNF/TrkB binding,
which led to elevated TrkB-FL mRNA and possibly cAMP/
CREB levels rather than GAP-43 induced neurite outgrowth.
This work reveals the importance of combined cues of cell-
adhesive interface and neurotrophin support during early de-
velopment of NPCs in vitro, along with the potential applica-
tion of bio-functionalized PEMs with adsorbed BDNF to
provide well-controlled local accessibility of the neurotro-
phic factor with sustained signal activation in vivo for SCI
treatment.
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APPENDIX
FIG. 9. (Color online) Chosen high resolution images from Fig. 6. Images
correspond to (a) No BDNF, (b) 50 ng/mL soluble BDNF, (c) 2.81 ng/cm2
adsorbed BDNF, and (d) 2.81 ng/cm2 BDNF inhibited groups.
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